Pancreatic Cancer Research

ResearcherColumbia UniversityActive in the last 2 years

Tannishtha Reya

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5956-8536; OpenAlex author ID A5054070387; NIH RePORTER profile ID 7036992. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 4)
Trials
0
Grants
2
Labs led
2
Collaborators
36
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: 2 papers, 1 grant · 2020: none · 2021: 1 paper · 2022: none · 2023: 2 papers · 2024: none · 2025: none · 2026: 1 grant

Papers 6

  1. Single-cell mapping identifies MSI+ cells as a common origin for diverse subtypes of pancreatic cancer. Last author DOI 10.1016/j.ccell.2023.09.008↗
  2. Smarcd3 is an epigenetic modulator of the metabolic landscape in pancreatic ductal adenocarcinoma. Last author DOI 10.1038/s41467-023-35796-7↗
  3. Author Correction: Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring. Co-author DOI 10.1038/s41586-021-04176-w↗
  4. A Multiscale Map of the Stem Cell State in Pancreatic Adenocarcinoma. Last author DOI 10.1016/j.cell.2019.03.010↗
  5. Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring. Co-author DOI 10.1038/s41586-019-1130-6↗
  6. Image-based detection and targeting of therapy resistance in pancreatic adenocarcinoma. Last author DOI 10.1038/nature17988↗

Grants 2

  1. Molecular strategies for early detection and targeting of cancer R35CA197699↗
  2. Musashi-mediated control of pancreatic cancer growth and progression R01CA186043↗

Closest collaborators

The 25 strongest of 36 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Andrew M. Lowy · 6 shared papers, 1 shared grant, 2016–2023 · strength 0.92
  2. Nikki K. Lytle · 6 shared papers, 2016–2023 · strength 0.52
  3. Daniel D. Von Hoff · 4 shared papers, 2019–2023 · strength 0.34
  4. Lesley Paige Ferguson · 3 shared papers, 2019–2023 · strength 0.33
  5. Nirakar Rajbhandari · 3 shared papers, 2019–2023 · strength 0.33
  6. Raymond G. Fox · 3 shared papers, 2016–2023 · strength 0.24
  7. Martin Wartenberg · 2 shared papers, 2019–2023 · strength 0.20
  8. José A. Galván · 2 shared papers, 2019–2023 · strength 0.20
  9. Eva Karamitopoulou · 2 shared papers, 2019–2023 · strength 0.20
  10. Haiyong Han · 2 shared papers, 2019–2023 · strength 0.20
  11. Michael Anthony Hollingsworth · 3 shared papers, 2016–2021 · strength 0.19
  12. Paul M. Grandgenett · 3 shared papers, 2016–2021 · strength 0.19
  13. Timothy R. Donahue · 2 shared papers, 2019–2021 · strength 0.14
  14. Kathleen E. DelGiorno · 2 shared papers, 2019–2021 · strength 0.14
  15. Gaoyang Liang · 2 shared papers, 2019–2021 · strength 0.14
  16. Geoffrey Myles Wahl · 2 shared papers, 2019–2021 · strength 0.14
  17. Maya Ridinger-Saison · 2 shared papers, 2019–2021 · strength 0.14
  18. Yu Shi · 2 shared papers, 2019–2021 · strength 0.14
  19. Ruilian Xu · 2 shared papers, 2019–2021 · strength 0.14
  20. Peiwu Huang · 2 shared papers, 2019–2021 · strength 0.14
  21. Corina E. Antal · 2 shared papers, 2019–2021 · strength 0.14
  22. Carlos Roberto Becerra · 2 shared papers, 2019–2021 · strength 0.14
  23. Eric Andrew Collisson · 2 shared papers, 2019–2021 · strength 0.14
  24. Tony R. Hunter · 2 shared papers, 2019–2021 · strength 0.14
  25. Erkut Hasan Borazanci · 2 shared papers, 2019–2021 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.